All peptide products sold by Pure Peptides are labeled for research purposes only and are not intended for human consumption. Nonetheless, researchers must understand the regulatory framework that governs the acquisition, storage, and use of these reagents.
Key Regulatory Bodies
- U.S. Food and Drug Administration (FDA): Peptides are regulated as research chemicals; any claim of therapeutic use triggers IND (Investigational New Drug) requirements.
- DEA (Drug Enforcement Administration): Most peptides are not controlled substances, but certain analogs may fall under Schedule I if they mimic prohibited compounds.
- International Standards: EU’s Cosmetic Regulation (EC) No 1223/2009 and the UK’s MHRA provide similar research‑only caveats.
What “Research Use Only” Means Legally
When a product is marketed as research‑only, the seller (Pure Peptides) disclaims any responsibility for clinical or therapeutic use. This protects both the vendor and the purchaser, but it also places the onus on the researcher to avoid off‑label applications.
Documentation Required for Compliance
- Certificate of Analysis (COA): Must be retained for each batch to prove authenticity and purity.
- Material Safety Data Sheet (MSDS): Provides handling and disposal instructions.
- Institutional Review Board (IRB) Approval: If the peptide will be used in animal studies or ex‑vivo human tissue, proper ethical clearance is mandatory.
Import and Export Considerations
When shipping peptides across borders, include the following documentation:
- Commercial invoice stating “research chemicals – not for human consumption.”
- Export licenses if required by the originating country.
- Import permits for the destination country, especially for high‑purity or labeled peptides.
Storage, Disposal, and Environmental Responsibility
Even though the peptides are research‑grade, they must be handled responsibly:
- Store in locked, temperature‑controlled cabinets.
- Dispose of unused powder according to local hazardous waste guidelines.
- Do not flush solutions down the drain without neutralization.
Best Practices for Staying Compliant
- Keep an updated log of all peptide purchases, including batch numbers and COAs.
- Train lab personnel on the distinction between research and therapeutic use.
- Consult your institution’s compliance office before initiating any study that could be interpreted as pre‑clinical.
Conclusion
Understanding and adhering to regulatory guidelines protects your research integrity and avoids legal complications. Pure Peptides is committed to providing clear labeling, comprehensive documentation, and support to help you navigate these requirements confidently.